Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Brad Spiller

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|September 26, 2007
Viral heparin-binding complement inhibitors--a recurring themeAnna M Blom, Linda Mark, O Brad Spiller
Immunobiology|August 27, 2011
Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birthEamon P McGreal, Keziah Hearne, O Brad Spiller
Virology|March 16, 2004
The relevance of complement to virus biologyClare E Blue, O Brad Spiller, David J Blackbourn
Infection and Immunity|July 24, 2004
Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55Sylvie Hudault, O Brad Spiller, B Paul Morgan, et al.
Journal of Immunological Methods|May 28, 2008
Monoclonal anti-neutrophil elastase antibody characterisation: ability to block function, detect free versus serpin-complexed enzyme and stain intracellular granulesPhilip L Davies, Nicola C Maxwell, Sailesh Kotecha, et al.
Molecular Immunology|August 15, 2006
Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and moreLinda Mark, O Brad Spiller, Bruno O Villoutreix, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2009
Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphismMichael L Beeton, Victoria J Chalker, Sailesh Kotecha, et al.
The Journal of General Virology|April 16, 2005
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55)Miguel A Jimenez-Clavero, Estela Escribano-Romero, Victoria Ley, et al.
International Journal of Antimicrobial Agents|July 5, 2015
In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycinLucy L Furfaro, O Brad Spiller, Jeffrey A Keelan, et al.
Journal of Clinical Microbiology|July 24, 2015
Development of a Multilocus Sequence Typing Scheme for Molecular Typing of Mycoplasma pneumoniaeRebecca J Brown, Matthew T G Holden, O Brad Spiller, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|September 26, 2007
Viral heparin-binding complement inhibitors--a recurring themeAnna M Blom, Linda Mark, O Brad Spiller
Immunobiology|August 27, 2011
Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birthEamon P McGreal, Keziah Hearne, O Brad Spiller
Virology|March 16, 2004
The relevance of complement to virus biologyClare E Blue, O Brad Spiller, David J Blackbourn
Infection and Immunity|July 24, 2004
Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55Sylvie Hudault, O Brad Spiller, B Paul Morgan, et al.
Journal of Immunological Methods|May 28, 2008
Monoclonal anti-neutrophil elastase antibody characterisation: ability to block function, detect free versus serpin-complexed enzyme and stain intracellular granulesPhilip L Davies, Nicola C Maxwell, Sailesh Kotecha, et al.
Molecular Immunology|August 15, 2006
Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and moreLinda Mark, O Brad Spiller, Bruno O Villoutreix, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2009
Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphismMichael L Beeton, Victoria J Chalker, Sailesh Kotecha, et al.
The Journal of General Virology|April 16, 2005
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55)Miguel A Jimenez-Clavero, Estela Escribano-Romero, Victoria Ley, et al.
International Journal of Antimicrobial Agents|July 5, 2015
In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycinLucy L Furfaro, O Brad Spiller, Jeffrey A Keelan, et al.
Journal of Clinical Microbiology|July 24, 2015
Development of a Multilocus Sequence Typing Scheme for Molecular Typing of Mycoplasma pneumoniaeRebecca J Brown, Matthew T G Holden, O Brad Spiller, et al.
Pageof 5